Advisor Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $15K | Sell |
2,916
-2,982
| -51% | -$15.3K | ﹤0.01% | 4109 |
|
|
2019
Q3 | $30K | Sell |
5,898
-2,051
| -26% | -$10.4K | ﹤0.01% | 3721 |
|
|
2019
Q2 | $49K | Sell |
7,949
-3,280
| -29% | -$20.2K | ﹤0.01% | 3381 |
|
|
2019
Q1 | $53K | Sell |
11,229
-1,422
| -11% | -$6.71K | ﹤0.01% | 3343 |
|
|
2018
Q4 | $53K | Buy |
12,651
+12,158
| +2,466% | +$50.9K | ﹤0.01% | 3145 |
|
|
2018
Q3 | $3K | Hold |
493
| – | – | ﹤0.01% | 4779 |
|
|
2018
Q2 | $4K | Sell |
493
-27
| -5% | -$219 | ﹤0.01% | 4499 |
|
|
2018
Q1 | $4K | Buy |
520
+13
| +3% | +$100 | ﹤0.01% | 4521 |
|
|
2017
Q4 | $3K | Hold |
507
| – | – | ﹤0.01% | 4620 |
|
|
2017
Q3 | $4K | Sell |
507
-6,872
| -93% | -$54.2K | ﹤0.01% | 4383 |
|
|
2017
Q2 | $50K | Buy |
7,379
+6,796
| +1,166% | +$46.1K | ﹤0.01% | 2863 |
|
|
2017
Q1 | $6K | Buy |
583
+199
| +52% | +$2.05K | ﹤0.01% | 4066 |
|
|
2016
Q4 | $3K | Sell |
384
-978
| -72% | -$7.64K | ﹤0.01% | 4156 |
|
|
2016
Q3 | $9K | Buy |
+1,362
| New | +$9K | ﹤0.01% | 3640 |
|